Search

everythinglearnresearchcommunity

for

Search:↓

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Chemotherapy caused nail grooves and separation, but they healed after treatment stopped.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Erlotinib can cause hair loss and texture changes.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Higher doses of cranial irradiation are linked to permanent hair loss.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Permanent eyebrow correction can improve quality of life for those with eyebrow loss.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

Temporary hair loss can occur after brain AVM treatment but usually regrows in 8 weeks.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

St. John's wort skin oil may increase skin damage risk during radiotherapy.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

Permanent micropigmentation can help cancer survivors feel better about themselves by restoring eyebrows lost during chemotherapy.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.